SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss (Q61967178)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss |
clinical trial |
Statements
Safety and Efficacy Study of SPI-1005 for Prevention of Chemotherapy Induced Hearing Loss (English)
0 references
15 January 2018
0 references
26 June 2019
0 references
80
0 references
19 year
0 references
80 year
0 references